selected publications
-
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2.
Science advances.
2025
Academic Article
GET IT
Times cited: 5 - Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2. bioRxiv : the preprint server for biology. 2025 Article GET IT
-
Molecular architecture of the autoinhibited kinesin-1 lambda particle.
Science advances.
2022
Academic Article
GET IT
Times cited: 19 -
In situ cryo-electron tomography reveals filamentous actin within the microtubule lumen.
The Journal of cell biology.
2020
Academic Article
GET IT
Times cited: 26